Drug Shortage Report for IOPIDINE

Last updated on 2018-01-09 History
Report ID 24465
Drug Identification Number 00888354
Brand name IOPIDINE OPH SOL 1%
Common or Proper name APRACLONIDINE HCL
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Active Ingredient(s) APRACLONIDINE
Strength(s) 1%
Dosage form(s) LIQUID
Route of administration OPHTHALMIC
Packaging size (2 x 0.1mL) x 12
ATC code S01EA
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-10-03
Estimated end date 2018-01-24
Actual end date 2018-01-08
Shortage status Resolved
Updated date 2018-01-09
Company comments
Health Canada comments
Contact Address 385 BOUCHARD BLVD
DORVAL, QUEBEC
CANADA H9S 1A9
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2018-01-09 English Compare
v8 2018-01-08 French Compare
v7 2018-01-08 English Compare
v6 2017-12-04 French Compare
v5 2017-12-04 English Compare
v4 2017-10-05 French Compare
v3 2017-10-05 English Compare
v2 2017-10-05 English Compare
v1 2017-10-05 English Compare